Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Atossa Therapeutics, Inc.
Atossa Genetics Inc mainly focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
IPO Date: November 8, 2012
Sector: Healthcare
Industry: Biotech
Market Cap: $118.16M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.09 | 4.37%
Avg Daily Range (30 D): $0.02 | 2.82%
Avg Daily Range (90 D): $0.03 | 3.88%
Institutional Daily Volume
Avg Daily Volume: 1.74M
Avg Daily Volume (30 D): .66M
Avg Daily Volume (90 D): .61M
Trade Size
Avg Trade Size (Sh.): 365
Avg Trade Size (Sh.) (30 D): 284
Avg Trade Size (Sh.) (90 D): 267
Institutional Trades
Total Inst.Trades: 168
Avg Inst. Trade: $2.14M
Avg Inst. Trade (30 D): $3.98M
Avg Inst. Trade (90 D): $3.98M
Avg Inst. Trade Volume: .6M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $5.33M
Avg Closing Trade (30 D): $9.36M
Avg Closing Trade (90 D): $9.36M
Avg Closing Volume: 1.6M
   
News
Oct 14, 2024 @ 9:08 PM
Atossa Therapeutics to Present at the 2024 Maxim H...
Source: N/A
Jun 28, 2024 @ 12:30 PM
Atossa Therapeutics Announces Updated Protocol for...
Source: Atossa Therapeutics, Inc.
Jun 25, 2024 @ 1:40 PM
Are Medical Stocks Lagging Alvotech (ALVO) This Y...
Source: Zacks Equity Research
Jun 17, 2024 @ 12:30 PM
Atossa Set to Join Russell 3000® Index Effectiv...
Source: Atossa Therapeutics, Inc.
Jun 6, 2024 @ 1:40 PM
Is Atossa Genetics (ATOS) Stock Outpacing Its Medi...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.21 $-.05 $-.05
Diluted EPS $-.21 $-.05 $-.05
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -26.34M $ -6.72M $ -6.35M
Operating Income / Loss $ -28.06M $ -7.41M $ -7.15M
Cost of Revenue $ $ $
Net Cash Flow $ -12.88M $ M $ -3.68M
PE Ratio    
Splits
Apr 20, 2018:   1:12
Aug 26, 2016:   1:15